tirzepatide cease and desist Eli Lilly races to fend off competitors in weight-loss drug market Lilly demands doctors stop selling

The GI effects are attenuated, which is exactly why people microdose, but metabolic effects are also attenuated

[3] Retatrutide triple agonist review, PubMed

Tirzepatide is a medication used to treat type 2 diabetes, and it gained attention when patients reported experiencing headaches as a side effect

These results are consistent with SURPASS2, a 40week, openlabel, phase 3 trial in a cohort of patients with metformintreated T2D in which onceweekly tirzepatide (5, 10, or 15 mg) was noninferior and superior to semaglutide 1 mg for HbA1c reduction and produced substantially greater, dosedependent weight loss

It functions by mimicking natural hormones known as incretins, which stimulate insulin production in response to food intake